(Q44637684)

4 December 2017

Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection (English)

1 reference

4 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

26 March 2024

author name string

Marcelo Kugelmas

1

1 reference

4 December 2017

Thomas Bak

4

1 reference

4 December 2017

Michael Wachs

5

1 reference

4 December 2017

Lisa Forman

6

1 reference

4 December 2017

Igal Kam

7

1 reference

4 December 2017

Michael J. Osgood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586876

26 March 2024

James F. Trotter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586876

26 March 2024

Gregory T. Everson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586876

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14586876

26 March 2024

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1053%2Fjlts.2003.50233

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

https://onlinelibrary.wiley.com/doi/full/10.1053/jlts.2003.50233

26 March 2024

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

26 March 2024

published in

Liver Transplantation

1 reference

4 December 2017

9

1 reference

4 December 2017

11

1 reference

4 December 2017

1159-1165

1 reference

Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR: preliminary application to the liver transplantation model

4 December 2017

2

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

The association between hepatitis C infection and survival after orthotopic liver transplantation

26 March 2024

3

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Influence of immunosuppression on patient survival after liver transplantation for hepatitis C.

26 March 2024

4

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver

26 March 2024

5

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation

26 March 2024

6

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients

26 March 2024

7

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Impact of immunosuppressive therapy on recurrence of hepatitis C.

26 March 2024

8

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

26 March 2024

9

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

26 March 2024

10

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Long-term outcome of hepatitis C infection after liver transplantation

26 March 2024

11

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

26 March 2024

12

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin

26 March 2024

13

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin

26 March 2024

14

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

26 March 2024

15

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

26 March 2024

20

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

26 March 2024

21

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin

26 March 2024

22

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Hepatitis C infection in liver transplantation

26 March 2024

23

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C.

26 March 2024

24

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50233

26 March 2024

Identifiers

1 reference

4 December 2017

1 reference